Different cardiovascular profiles of three melanocortins in conscious rats; evidence for antagonism between γ2‐MSH and ACTH‐(1–24)
- 1 April 1997
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 120 (8) , 1561-1567
- https://doi.org/10.1038/sj.bjp.0701065
Abstract
We investigated the effects of [Nle4,d‐Phe7]α‐melanocyte‐stimulating hormone (NDP‐MSH), adrenocorticotropin‐(124) (ACTH‐(124)) and γ2‐MSH, three melanocortins with different agonist selectivity for the five cloned melanocortin receptors, on blood pressure and heart rate in conscious, freely moving rats following intravenous administration. As was previously found by other investigators as well as by us, γ2‐MSH, a peptide suggested to be an agonist with selectivity for the melanocortin MC3 receptor, caused a dose‐dependent, short lasting pressor response in combination with a tachycardia. Despite the fact that NDP‐MSH is a potent agonist of various melanocortin receptor subtypes, among which the melanocortin MC3 receptor, it did not affect blood pressure or heart rate, when administered i.v. in doses of up to 1000 nmol kg−1. ACTH‐(124) caused a dose‐dependent decrease in blood pressure in combination with a dose‐dependent increase in heart rate in a dose‐range from 15 to 500 nmol kg−1. The cardiovascular effects of ACTH‐(124) were independent of the presence of the adrenals. Pretreatment with ACTH‐(124) caused a pronounced, dose‐dependent parallel shift to the right of the dose‐response curve for the pressor and tachycardiac effects of γ2‐MSH. The antagonistic effect of ACTH‐(124) was already apparent following a dose of this peptide as low as 10 nmol kg−1, which when given alone had no intrinsic hypotensive activity. These results form further support for the notion that it is not via activation of one of the as yet cloned melanocortin receptors that γ‐MSH‐like peptides increase blood pressure and heart rate. The cardiovascular effects of ACTH‐(124) seem not to be mediated by the adrenal melanocortin MC2 receptors, for which ACTH‐(124) is a selective agonist, or by adrenal catecholamines. There appears to be a functional antagonism between ACTH‐(124) and γ2‐MSH, two melanocortins derived from a common precursor, with respect to their effect on blood pressure and heart rate. Whether this antagonism plays a (patho)physiological role remains to be shown. British Journal of Pharmacology (1997) 120, 1561–1567; doi:10.1038/sj.bjp.0701065Keywords
This publication has 27 references indexed in Scilit:
- Effect of γ-Melanocyte-Stimulating Hormone on Cerebral Blood Flow in RatsJournal of Cardiovascular Pharmacology, 1995
- Molecular Cloning and Characterisation of the Rat Fifth Melanocortin ReceptorBiochemical and Biophysical Research Communications, 1994
- Receptors for the melanocortin peptides in the central nervous systemCurrent Opinion in Endocrinology, Diabetes and Obesity, 1994
- Effect of ACTH-(4–10) and γ2-MSH on Blood Pressure After Intracerebroventricular and Intracisternal AdministrationJournal of Cardiovascular Pharmacology, 1993
- Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNAFEBS Letters, 1992
- The Cloning of a Family of Genes That Encode the Melanocortin ReceptorsScience, 1992
- Pressor and cardioaccelerator effects of gamma MSH and related peptidesLife Sciences, 1985
- Adrenal RegenerationNeuroendocrinology, 1980
- Depressor effect of synthetic peptides related to ACTH on blood pressure in ratsCellular and Molecular Life Sciences, 1976
- Non-Specific Effects of Synthetic Corticotrophin PolypeptidesInternational Archives of Allergy and Immunology, 1965